Person · CIK 1697422

Christopher R. Fenimore

EVP Finance CFO at Regeneron Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$30.3M

Noticed on Form 144$15.2M

Bought on Form 4$0

Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Regeneron Pharmaceuticals REGN	Common Stock	Directly	19,984	Aug 18, 2026 · Filing · EDGAR
Regeneron Pharmaceuticals REGN	Common Stock	By GRAT	2,695	Aug 30, 2018 · Filing · EDGAR
Regeneron Pharmaceuticals REGN	Common Stock	By Trust	1,897	Aug 18, 2026 · Filing · EDGAR
Regeneron Pharmaceuticals REGN	Common Stock	By 401(k) Plan	1,574	Aug 18, 2026 · Filing · EDGAR
Regeneron Pharmaceuticals REGN	Common Stock	by Trust for Daugh	25	Aug 18, 2026 · Filing · EDGAR
Regeneron Pharmaceuticals REGN	Common Stock	by Trust for Son	25	Aug 18, 2026 · Filing · EDGAR
Regeneron Pharmaceuticals REGN	Non-Qualified Stock Option (right to buy) exercise $381.92, expires Dec 16, 2026, into Common Stock	Directly	6,000	Aug 18, 2026 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)
Q3 2024	$6.8M	$6.8M
Q1 2024	$4.7M	$4.7M
Q4 2023	$3.7M	$3.7M
Q1 2023	$1.8M	Not machine-readable
Q4 2022	$3.8M	Not machine-readable
Q3 2021	$3.1M	Not machine-readable
Q3 2020	$2.4M	Not machine-readable
Q2 2020	$2.7M	Not machine-readable
Q4 2019	$633K	Not machine-readable
Q4 2018	$663K	Not machine-readable

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Regeneron Pharmaceuticals REGN · UBS Financial Services · No 10b5-1 plan stated · 2 notices
Aug 28, 2024	5,680 · ~$6.8M	Aug 28, 2024	Sold as noticed Sold 5,680 in 10 sales, Aug 28 to Aug 28 · $6.8M Form 4	Filing · EDGAR
Feb 9, 2024	4,919 · ~$4.7M	Feb 9, 2024	Sold as noticed Sold 4,919 in 6 sales, Feb 9 to Feb 9 · $4.7M Form 4	Filing · EDGAR
Regeneron Pharmaceuticals REGN · UBS Financial Services · 10b5-1 plan adopted Aug 25, 2023 · 1 notice
Dec 21, 2023	4,378 · ~$3.7M	Dec 21, 2023	Sold as noticed Sold 4,378 in 4 sales, Dec 21 to Dec 27 · $3.7M Form 4 (1) · Form 4 (2)	Filing · EDGAR
Sales without a matching Form 144 · 64 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 2,192 at $806.47 on Mar 23, 2023 · $1.8M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 1,844 at $749.00 on Oct 5, 2022 · $1.4M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 3,346 at $724.00 on Oct 3, 2022 · $2.4M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 14 at $665.21 on Aug 23, 2021 · $9K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 70 at $663.05 on Aug 23, 2021 · $46K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 1 at $662.78 on Aug 23, 2021 · $663 (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 88 at $661.89 on Aug 23, 2021 · $58K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 23 at $660.33 on Aug 23, 2021 · $15K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 9 at $659.33 on Aug 23, 2021 · $6K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 4,576 at $655.00 on Aug 23, 2021 · $3M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 11 at $658.00 on Jul 21, 2020 · $7K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 82 at $647.79 on Jul 21, 2020 · $53K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 155 at $646.82 on Jul 21, 2020 · $100K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 72 at $645.33 on Jul 21, 2020 · $46K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 303 at $644.57 on Jul 21, 2020 · $195K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 691 at $643.49 on Jul 21, 2020 · $445K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 676 at $642.39 on Jul 21, 2020 · $434K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 855 at $641.58 on Jul 21, 2020 · $549K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 113 at $640.61 on Jul 21, 2020 · $72K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 75 at $639.64 on Jul 21, 2020 · $48K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 306 at $638.51 on Jul 21, 2020 · $195K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 154 at $637.88 on Jul 21, 2020 · $98K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 216 at $636.56 on Jul 21, 2020 · $137K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 294 at $596.36 on Jun 16, 2020 · $175K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 403 at $595.50 on Jun 16, 2020 · $240K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 747 at $594.35 on Jun 16, 2020 · $444K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 109 at $593.25 on Jun 16, 2020 · $65K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 214 at $592.20 on Jun 16, 2020 · $127K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 233 at $591.61 on Jun 16, 2020 · $138K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 153 at $590.70 on Jun 16, 2020 · $90K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 147 at $588.80 on Jun 16, 2020 · $87K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 373 at $587.55 on Jun 16, 2020 · $219K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 413 at $586.54 on Jun 16, 2020 · $242K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 130 at $585.76 on Jun 16, 2020 · $76K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 99 at $584.62 on Jun 16, 2020 · $58K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 111 at $583.06 on Jun 16, 2020 · $65K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 18 at $582.69 on Jun 16, 2020 · $10K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 112 at $581.40 on Jun 16, 2020 · $65K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 68 at $497.99 on Apr 1, 2020 · $34K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 37 at $494.16 on Apr 1, 2020 · $18K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 174 at $493.24 on Apr 1, 2020 · $86K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 134 at $492.45 on Apr 1, 2020 · $66K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 70 at $491.65 on Apr 1, 2020 · $34K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 201 at $489.48 on Apr 1, 2020 · $98K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 137 at $488.76 on Apr 1, 2020 · $67K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 3 at $484.14 on Apr 1, 2020 · $1K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 124 at $483.58 on Apr 1, 2020 · $60K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 62 at $482.09 on Apr 1, 2020 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 58 at $480.28 on Apr 1, 2020 · $28K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 69 at $479.00 on Apr 1, 2020 · $33K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 63 at $478.77 on Apr 1, 2020 · $30K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 51 at $378.27 on Dec 13, 2019 · $19K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 346 at $377.38 on Dec 13, 2019 · $131K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 470 at $376.27 on Dec 13, 2019 · $177K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 624 at $375.58 on Dec 13, 2019 · $234K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 191 at $374.82 on Dec 13, 2019 · $72K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 200 at $362.45 on Dec 20, 2018 · $72K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 100 at $361.65 on Dec 20, 2018 · $36K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 500 at $360.40 on Dec 20, 2018 · $180K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 200 at $359.38 on Dec 20, 2018 · $72K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 200 at $358.27 on Dec 20, 2018 · $72K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 200 at $357.50 on Dec 20, 2018 · $72K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 348 at $356.27 on Dec 20, 2018 · $124K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Regeneron Pharmaceuticals (REGN): Sold 100 at $355.14 on Dec 20, 2018 · $36K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Regeneron Pharmaceuticals REGN EVP Finance CFO · filings 2017 to 2026 · sold $30.3M · $15.2M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 18, 2026	Option or RSU exercised or converted	+6,283	$381.92	$2.4M	24,583 direct	Filing · EDGAR
Aug 18, 2026	Shares withheld for tax or exercise price	−4,599	$813.47	$3.7M	19,984 direct	Filing · EDGAR
Aug 18, 2026	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−6,283			6,000 direct	Filing · EDGAR
Dec 8, 2025	Shares withheld for tax or exercise price	−992	$712.94	$707K	18,300 direct	Filing · EDGAR
Dec 5, 2025	Grant or award from the company	+3,027			19,292 direct	Filing · EDGAR
Dec 5, 2025	Grant or award from the company Non-Qualified Stock Option (right to buy)	+14,924			14,924 direct	Filing · EDGAR
Dec 16, 2024	Shares withheld for tax or exercise price	−491	$730.81	$359K	16,265 direct	Filing · EDGAR
Dec 9, 2024	Shares withheld for tax or exercise price	−1,140	$787.00	$897K	16,756 direct	Filing · EDGAR
Dec 6, 2024	Grant or award from the company	+2,591			17,896 direct	Filing · EDGAR
Dec 6, 2024	Grant or award from the company Non-Qualified Stock Option (right to buy)	+9,979			9,979 direct	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−228	$1,204.79	$275K	966 2021 GRAT	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−766	$1,205.44	$923K	200 2021 GRAT	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−200	$1,206.30	$241K	0 2021 GRAT	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−2,237	$1,204.71	$2.7M	1,378 2022 GRAT	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−928	$1,205.49	$1.1M	450 2022 GRAT	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−450	$1,206.15	$543K	0 2022 GRAT	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−236	$1,205.67	$285K	225 by Trust for Daugh	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−200	$1,206.70	$241K	25 by Trust for Daugh	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−235	$1,205.67	$283K	225 by Trust for Son	Filing · EDGAR
Aug 28, 2024	Open-market or private sale	−200	$1,206.67	$241K	25 by Trust for Son	Filing · EDGAR
Feb 9, 2024	Open-market or private sale	−344	$950.49	$327K	18,947 direct	Filing · EDGAR
Feb 9, 2024	Open-market or private sale	−487	$951.39	$463K	18,460 direct	Filing · EDGAR
Feb 9, 2024	Open-market or private sale	−1,046	$952.62	$996K	17,414 direct	Filing · EDGAR
Feb 9, 2024	Open-market or private sale	−1,342	$953.47	$1.3M	16,072 direct	Filing · EDGAR
Feb 9, 2024	Open-market or private sale	−1,100	$954.57	$1.1M	14,972 direct	Filing · EDGAR
Feb 9, 2024	Open-market or private sale	−600	$955.00	$573K	14,372 direct	Filing · EDGAR
Jan 23, 2024	Option or RSU exercised or converted	+5,000	$555.67	$2.8M	21,860 direct	Filing · EDGAR
Jan 23, 2024	Shares withheld for tax or exercise price	−3,986	$948.50	$3.8M	17,874 direct	Filing · EDGAR
Jan 23, 2024	Option or RSU exercised or converted	+5,000	$399.66	$2M	22,874 direct	Filing · EDGAR
Jan 23, 2024	Shares withheld for tax or exercise price	−3,583	$948.50	$3.4M	19,291 direct	Filing · EDGAR
Jan 23, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−5,000			0 direct	Filing · EDGAR
Jan 23, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−5,000			0 direct	Filing · EDGAR
Jan 3, 2024	Option or RSU exercised or converted	+5,000	$555.67	$2.8M	19,372 direct	Filing · EDGAR
Jan 3, 2024	Shares withheld for tax or exercise price	−4,043	$912.30	$3.7M	15,329 direct	Filing · EDGAR
Jan 3, 2024	Option or RSU exercised or converted	+5,000	$399.66	$2M	20,329 direct	Filing · EDGAR
Jan 3, 2024	Shares withheld for tax or exercise price	−3,469	$912.30	$3.2M	16,860 direct	Filing · EDGAR
Jan 3, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−5,000			5,000 direct	Filing · EDGAR
Jan 3, 2024	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−5,000			5,000 direct	Filing · EDGAR
Dec 27, 2023	Sale under a 10b5-1 plan	−2,448	$856.71	$2.1M	14,372 direct	Filing · EDGAR
Dec 22, 2023	Sale under a 10b5-1 plan	−250	$846.27	$212K	16,820 direct	Filing · EDGAR
Dec 21, 2023	Sale under a 10b5-1 plan	−456	$843.79	$385K	18,294 direct	Filing · EDGAR
Dec 21, 2023	Sale under a 10b5-1 plan	−1,224	$844.09	$1M	17,070 direct	Filing · EDGAR
Dec 12, 2023	Shares withheld for tax or exercise price	−2,552	$856.71	$2.2M	18,750 direct	Filing · EDGAR
Dec 11, 2023	Shares withheld for tax or exercise price	−1,276	$844.09	$1.1M	21,562 direct	Filing · EDGAR
Dec 11, 2023	Shares withheld for tax or exercise price	−260	$844.09	$219K	21,302 direct	Filing · EDGAR
Dec 8, 2023	Shares withheld for tax or exercise price	−474	$843.79	$400K	20,468 direct	Filing · EDGAR
Dec 8, 2023	Grant or award from the company	+2,370			22,838 direct	Filing · EDGAR
Dec 8, 2023	Grant or award from the company Non-Qualified Stock Option (right to buy)	+8,499			8,499 direct	Filing · EDGAR
Aug 23, 2023	Option or RSU exercised or converted	+7,000	$399.66	$2.8M	26,140 direct	Filing · EDGAR
Aug 23, 2023	Shares withheld for tax or exercise price	−5,198	$842.66	$4.4M	20,942 direct	Filing · EDGAR
Aug 23, 2023	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−7,000			10,000 direct	Filing · EDGAR
Mar 23, 2023	Sale under a 10b5-1 plan	−2,192	$806.47	$1.8M	18,409 direct	Filing · EDGAR
Feb 3, 2023	Option or RSU exercised or converted	+5,000	$270.43	$1.4M	23,581 direct	Filing · EDGAR
Feb 3, 2023	Shares withheld for tax or exercise price	−3,286	$774.29	$2.5M	20,295 direct	Filing · EDGAR
Feb 3, 2023	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−5,000			0 direct	Filing · EDGAR
Dec 16, 2022	Grant or award from the company	+1,926			18,581 direct	Filing · EDGAR
Dec 16, 2022	Grant or award from the company Non-Qualified Stock Option (right to buy)	+7,111			7,111 direct	Filing · EDGAR
Dec 9, 2022	Shares withheld for tax or exercise price	−247	$753.28	$186K	16,655 direct	Filing · EDGAR
Oct 26, 2022	Gift	−871			0 by 2018 GRAT	Filing · EDGAR
Oct 26, 2022	Gift	+436			461 by Trust for Daugh	Filing · EDGAR

134 earlier transactions are in the filing list below.

All 43 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Aug 20, 2026	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 9, 2025	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 18, 2024	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 10, 2024	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Aug 29, 2024	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Aug 28, 2024	Form 144	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Feb 12, 2024	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Feb 9, 2024	Form 144	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Jan 25, 2024	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Jan 4, 2024	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 29, 2023	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 26, 2023	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 21, 2023	Form 144	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 14, 2023	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 12, 2023	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Aug 25, 2023	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Mar 27, 2023	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Feb 7, 2023	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 20, 2022	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 13, 2022	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Oct 7, 2022	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Oct 5, 2022	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Apr 11, 2022	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Apr 1, 2022	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 14, 2021	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 10, 2021	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Aug 25, 2021	Form 4/A	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Aug 24, 2021	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 11, 2020	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Jul 22, 2020	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Jun 17, 2020	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Apr 3, 2020	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Jan 27, 2020	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 23, 2019	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 13, 2019	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Apr 18, 2019	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Jan 18, 2019	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 20, 2018	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 14, 2018	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Aug 31, 2018	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Jan 17, 2018	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Dec 13, 2017	Form 4	Regeneron Pharmaceuticals REGN	Filing · EDGAR
Mar 2, 2017	Form 3	Regeneron Pharmaceuticals REGN	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 5, 2026, 8:04 PM ET. The filing on SEC.gov is the record.